Dr. Al Rabeeah: Saudi Arabia has provided more than $713 million to contribute in addressing COVID-19 pandemic globally


(MENAFN- Saudi Press Agency) Riyadh, April 16, 2021, SPA -- Advisor at the Royal Court and Supervisor General of King Salman Humanitarian Aid and Relief Center (KSrelief) Dr. Abdullah bin Abdulaziz Al Rabeeah, pointed out that that the Kingdom of Saudi Arabia has so far provided more than $713 million to contribute in addressing the novel coronavirus pandemic (COVID-19) globally and help countries in need in addressing it.
This came during his participation today in the meeting of the Global Alliance for Vaccines and Immunization (GAVI) through video conferencing technology.
Dr. Al Rabeeah said that we live today under difficult conditions because of COVID-19 pandemic, due to which the world faces many health and economic challenges and many other challenges. He added that these challenges demonstrated the importance of unified global efforts to confront the pandemic, indicating that the Kingdom provided, during its hosting of the G20 summit for the year 2020, $500 to support international efforts to address COVID-19 pandemic and to manufacture and distribute an anti-virus vaccine.
He affirmed that we, as members of GVAI Covax initiative, are still far from achieving our goals and objectives, but we are moving forward in carrying out our tasks, stating that we have a great responsibility to reconsider increasing global production and distribution of vaccine and easing export restrictions, all of which hinder efforts to accomplish our mission.
--SPA
14:56 LOCAL TIME 11:56 GMT
0012

MENAFN16042021000078011016ID1101927943


Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.